TNFRSF8 and lymphoproliferative syndrome: Because CD30 serves as a diagnostic marker for the CD30 lymphoproliferative disorders, has a limited expression profile on normal cells and tissues, and has apoptosis-inducing characteristics, it has been evaluated as a target for immunotherapy [95,96].